Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL

This publication has 20 references indexed in Scilit:

• PROSTATE CANCER DETECTION AT LOW PROSTATE SPECIFIC ANTIGEN
  Journal of Urology, 2000
• A COMPARATIVE ANALYSIS OF SEXTANT AND AN EXTENDED 11-CORE MULTISITE DIRECTED BIOPSY STRATEGY
  Journal of Urology, 2000
• Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model
  Urology, 1999
• Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data
  Statistics in Medicine, 1998
• Evaluation of ProstAsure Index in the Detection of Prostate Cancer: a Preliminary Report
  Urology, 1998
• Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements
  JAMA, 1997
• Radiation therapy for T1 and T2 prostate cancer: Prostate-specific antigen and disease outcome
  Urology, 1995
• Cost-effective prostate cancer detection. Reduction of low-yield biopsies
  Cancer, 1994
• SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMY
  Urologic Clinics of North America, 1993
• The Distribution of Prostate Specific Antigen in Men Without Clinical or Pathological Evidence of Prostate Cancer: Relationship to Gland Volume and Age
  Journal of Urology, 1992